2261.80
-2.05%
Motilal Oswal
MANKIND has a strategic roadmap for growth through expansion in high entry barrier innovative product launches in the chronic/consumer segment and other adjacencies, transitioning from sexual wellness to consumer wellness in the over-the counter (OTC) space.
Number of FII/FPI investors decreased from 648 to 627 in Sep 2025 qtr
More from Mankind Pharma Ltd.
Recommended